Abstract
Information for control objects that are assigned risk categories is collected, processed, analyzed and recorded. The pharmaceutical manufacturer enters into an agreement with the recipient of the products on the exchange of data on the safety of such products in order to identify and study possible problems related to the safety of use, as well as to confirm social responsibility for the safety of drugs put into circulation.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)
Paper Title
Journal
Date